Navigation Links
Neuartige Krebsimmuntherapie für den Beginn klinischer Studien bereit
Date:4/16/2013

LAWRENCEBURG, Indiana, 17. April 2013 /PRNewswire/ -- Die PDS Biotechnology Corporation präsentierte auf dem World Vaccine Congress in Washington DC heute eine Zusammenfassung präklinischer Daten, die das Unternehmen zu seiner führenden Krebsimmuntherapie PDS0101 zusammengestellt hat. Das Produkt beruht auf der bahnbrechenden und proprietären Nanotechnologie-Impfstoff-Plattform Versamune™ des Unternehmens. Überdies gab PDS Biotechnology bekannt, dass die FDA dem IND-Antrag (Investigational New Drug) des Unternehmens zugestimmt hat und PDS0101 fortan an menschlichen Patienten getestet werden darf.

PDS0101 ist eine erstklassige Immuntherapie, die zur Behandlung von Krebs und Infektionskrankheiten im Zusammenhang mit dem humanen Papillomvirus entwickelt wird, darunter Gebärmutterhalskrebs, Kopf- und Halskrebs sowie zervikale intraepitheliale Neoplasien. Präsident und CEO Dr. Frank Bedu-Addo präsentierte äußerst vielversprechende präklinische Daten zur Wirksamkeit und Sicherheit des Produkts. Diese belegen, dass Tumoren ohne die typischen Sicherheitsbedenken aktueller immuntherapeutischer Verfahren beseitigt werden können. PDS0101 ist auf eine Stärkung des Immunsystems ausgelegt, sodass Zellen des körpereigenen Immunsystems zur gezielten Erkennung, Zielerfassung und Abtötung spezifischer Krebszellen eingesetzt werden können. Darüber hinaus ist PDS0101 auch auf eine Senkung der Anzahl bestimmter immunsuppressiver Zellen ausgelegt, die unser Immunsystem daran hindern, Krebszellen aufzuspüren und direkt anzugreifen. „Sollten die präklinischen Ergebnisse im Rahmen klinischer Untersuchungen reproduziert werden können, würde dies bei der Entwicklung von sicheren und wirksamen Krebstherapien einen gigantischen Schritt nach vorn bedeuten", so Frank
'/>"/>

SOURCE PDS Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
2. Janssen Launches EXPLORER, Global Cardiovascular Research Program, Beginning with Five New Studies in Patients with Unmet Medical Needs
3. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
4. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
5. MR Solutions bringt vollständige Reihe heliumfreier präklinischer Magnetresonanztomographen auf den Markt
6. Philips ermöglicht noch besseren Zugang zu Behandlungen für häufige Todesursache in den USA durch Bereitstellung seines einmillionsten AED
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Bloomage BioTechnology Corporation Limited ("Bloomage" or "The ... the South Korean BioTech Company Medytox Inc. ("Medytox", Stock ... develop and promote Type A Botulinum Toxin ("Botulinum Toxin") ... Medytox, the Botulinum Toxin brand, occupies the highest ... company in the world successfully developed and produced Botulinum ...
(Date:7/27/2015)... Belgium , July 27, 2015 /PRNewswire/ ... life sciences company focused on developing blood-based diagnostic tests ... conditions, today announced that it has engaged the services ... Specimen Solutions, Inc. (GSS), to support initial U.S. market ... Under the agreement, GSS will target ...
(Date:7/27/2015)... PITTSBURGH , July 27, 2015   ... and the nation,s leader in online dermatology solutions, ... Active States The company has contractual relationships ... 114% since December 2014. Dermatologists and ... significant growth in the number of providers delivering ...
Breaking Medicine Technology:Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Iagnosis Reports Significant Growth YTD 2015 2
... Reportlinker.com announces that a new market research ... Assistive Devices for Special Needs: Technologies and ... THIS REPORT CONTAINS ... for several categories of special needs, including cognitive ...
... Reportlinker.com announces that a new market research ... Triple Analysis: Colorectal Cancer, Lung Cancer and ... This triple analysis focuses on cancer drug ... Lymphoma. Each of these three individual parts is ...
Cached Medicine Technology:Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 2Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 3Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 4Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 5Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 6Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 7Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 8Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 9Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 10Reportlinker Adds Assistive Devices for Special Needs: Technologies and Global Markets 11Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma 2Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma 3Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma 4Reportlinker Adds Triple Analysis: Colorectal Cancer, Lung Cancer and Lymphoma 5
(Date:7/28/2015)... , ... July 28, 2015 , ... Fertility specialist ... as a “Top Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors ... hundreds of her esteemed colleagues and peers in the metro area as one of ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is reminded ... caution when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent report ... 3, 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in Last ...
(Date:7/28/2015)... , ... July 28, 2015 , ... A new study ... Easy Fibromyalgia, Study Says " sheds light on a possible new treatment option for ... two months of regular HBOT sessions, at least five per week, patients experienced a ...
(Date:7/28/2015)... ... July 28, 2015 , ... A ... Mets' David Wright's Spinal Stenosis Injury" discussed baseball player David Wright’s spinal stenosis ... acquired lumbar stenosis, brought on by degenerative changes in the spine, rather than ...
(Date:7/28/2015)... ... July 28, 2015 , ... The PULs ... Sudden Death, or Angina), many of whom are missed by conventional evaluation ... with active yet undetected sub-clinical disease, who are at risk of experiencing a ...
Breaking Medicine News(10 mins):Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2
... estimates savings of more than $60 million over 11 years ... of air bags and seat belts significantly reduces injuries to ... and also lowers in-hospital death rates, injury severity and hospital-acquired ... It also suggests that optimal use of air bags could ...
... Ill. Recent studies have linked sleep loss ... obesity, diabetes, high blood pressure and stroke. The ... discussed by more than 5,000 scientists and sleep specialists ... Associated Professional Sleep Societies convenes at the Baltimore Convention ...
... The Joint Annual Meeting of the American Society of Plant ... y Biologia Molecular de Plantas will be held June 2225, ... , A major theme of this year,s annual meeting ... in the America,s. Presentations will also focus on ...
... clinicians identify best treatment ... risk of heart disease, BIRMINGHAM, Ala., May 28 ... its VAP,Cholesterol Test in booth No. 4202 at the American ... June 6 -,10, 2008, at the Moscone Convention Center in ...
... China, May 28 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, ... or ,the Company,), a,manufacturer, marketer and distributor of ... that it has engaged MSPC,Certified Public Accountants and ... May 21, 2008. The Company terminated its,contract with ...
... to complete electronic records, CINCINNATI and MONTREAL, ... STRM ) and Emergis Inc., a TELUS company,today ... and,workflow solution at the eight hospitals representing the ... McGill University,Health Centre (MUHC). The module is integrated ...
Cached Medicine News:Health News:Air Bags-Seat Belts Cut Injuries, Deaths, Costs 2Health News:Experts to discuss sleep science and the health risks of sleep disorders in Baltimore this June 2Health News:Experts to discuss sleep science and the health risks of sleep disorders in Baltimore this June 3Health News:ASPB engages Latin America colleagues at Annual Meeting in Merida, Mexico June 22-25 2Health News:ASPB engages Latin America colleagues at Annual Meeting in Merida, Mexico June 22-25 3Health News:Atherotech to Exhibit The VAP Test at ADA 2008 Meeting in San Francisco 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 3Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 2Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 3Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 4Health News:Streamline Health's Document Management Solution Integrated into Oacis, Allowing Clinicians to Access Patients' Information - Either Scanned or Electronic 5
White Standard Girdle...
This compression garment can be used immediatlely following Abdominoplasty, Tram Flap, Abdominal Liposuction, Lipoplasty, Suction Lipectomy, Stomach Liposuction, Liposculpture and Tummy Tuck procedur...
Below Knee Girdle, High Waist...
Short Girdle, Mid-thigh, Front Closure...
Medicine Products: